Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

AstraZeneca PLC (AZN) had Revenue of $13.59B for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$13.59B
Net Income	$2.92B
Cost of Goods Sold	$2.24B
Gross Profit	$11.35B
Operating Expenses	$9.91B
Operating Income	$3.67B
Non-Operating Income/Expense	$-272.00M
Pre-Tax Income	$3.40B
Normalized Pre-Tax Income	$3.40B
Income after Taxes	$2.92B
Income from Continuous Operations	$2.92B
Consolidated Net Income/Loss	$2.92B
Normalized Income after Taxes	$2.92B
EBIT	$3.67B
EBITDA	$4.96B
Weighted-Average Shares Outstanding (Basic)	3.10B
Weighted-Average Shares Outstanding (Diluted)	3.12B
Earnings per Share (EPS) (Basic)	$0.94
Earnings per Share (EPS) (Diluted)	$0.94
Balance Sheet Financials
Current Assets	$26.14B
Property, Plant, and Equipment	$10.82B
Long-Term Assets	$80.11B
Total Assets	$106.25B
Current Liabilities	$29.13B
Long-Term Debt	$26.69B
Long-Term Liabilities	$35.99B
Total Liabilities	$65.12B
Common Equity	$41.13B
Tangible Shareholders Equity	$-17.55B
Shareholders Equity	$41.13B
Common Shares Outstanding	--
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.71B
Cash Flow from Investing Activities	$-1.25B
Cash Flow from Financial Activities	$-2.71B
Beginning Cash	$5.43B
End Cash	$5.21B
Increase/Decrease in Cash	$-222.00M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-3.35B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.39
Debt to Equity Ratio	0.73
Gross Margin	83.51%
Operating Margin	27.04%
EBIT Margin	27.04%
EBITDA Margin	--
Pre-Tax Profit Margin	25.04%
Profit Margin	21.50%
Free Cash Flow	$3.29B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	0.38
Receiveable Turnover	0.92
Days Sales in Receivables	98.13
Return on Equity	7.10%
Return on Tangible Equity	-16.64%
Return on Assets	2.75%
Return on Investments	4.31%
Book Value Per Share	--
Free Cash Flow per Share	$1.05
Operating Cash Flow per Share	$1.19

Data from Zacks Investment Research, Inc.